Market Cap | 94.53M | P/E | 151.71 | EPS this Y | - | Ern Qtrly Grth | -66.50% |
Income | 1.04M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | 3.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -8.00% |
Recommedations | - | Quick Ratio | 0.06 | Shares Outstanding | 5.16M | 52W Low Chg | 7.00% |
Insider Own | 1.09% | ROA | -0.77% | Shares Float | 1.69M | Beta | 0.01 |
Inst Own | 2.01% | ROE | - | Shares Shorted/Prior | 3.42K/6.69K | Price | 10.62 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 28,883 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 843 | Change | 0.14% |
Arisz Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to pursue targets in the healthcare industry in North America and Europe. The company was incorporated in 2021 and is based in New York, New York.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Hindle-Yang Fang | Chief Executive Offi.. Chief Executive Officer | Jan 21 | Sell | 9.75 | 128,206 | 1,250,008 | 1,746,683 | 01/25/22 |
Arisz Investment LLC | 10% Owner 10% Owner | Jan 21 | Sell | 9.75 | 128,206 | 1,250,008 | 1,746,683 | 01/25/22 |